Skip to content
Screener

Bruker BRKR Share Buybacks

Share Buybacks at other companies

Thermo Fisher Scientific logo
Thermo Fisher ScientificTMO
-$7B
Danaher logo
DanaherDHR
$894M
TEC
Bio-TechneTECH
$24K
WAT
Waters CorporationWAT
-$2M-747%
Agilent Technologies logo
Agilent TechnologiesA
$65M-60.6%
Cytek Biosciences, Inc. logo
Cytek Biosciences, Inc.CTKB
$0-100%

Other financials

Income statement

See full
Revenue$838.5M+5.2%
Gross profit$416.0M+16.2%
Operating income-$65.3M-649%
Net income-$52.0M-784%
EPS (diluted)-$0.41-920%

Balance sheet

See full
Cash & equivalents$189.1M+96.6%
Total debt$1.8B-25.1%
Total equity$2.4B+31.9%
Total assets$6.1B-4.5%

Cash flow

See full
Operating cash flow-$77.4M+39.3%
CapEx$28.8M+35.2%
Free cash flow-$106.2M+28.6%

Valuation

See full
Market cap$7.99B+71.7%
Enterprise value$9.62B+37.7%
P/S2.3×+0.9×

Profitability

See full
Gross margin46.4%-1.8pp
Operating margin-0.9%-6.2pp
Net margin-0.6%-10.0pp
FCF margin2.7%+1.3pp

Returns & leverage

See full
Return on equity-1%-21.2pp
Debt / equity0.8×-0.6×
Current ratio1.8×+0.2×

Where this comes from

Reported directly by Bruker in its filing.

Tagged under the XBRL concept us-gaap:PaymentsForRepurchaseOfCommonStock.

The source filing: Bruker’s 10-Q, filed May 7, 2026.

Filed
May 7, 2026, 4:09 PM EDT
Fiscal quarter
Q1 FY2026
Calendar quarter
Q1 2026
Accession
0001193125-26-211889
Line itemThree Months Ended March 31, 2026Three Months Ended March 31, 2025
Proceeds from long-term debt2.9
Payment of dividends to Series A Mandatory Convertible Preferred Shareholders(11.0)
Payment of dividends to common shareholders(7.6)(7.7)
Repurchase of common stock(10.0)
Other financing activities, net(5.0)(0.7)
Net cash used in financing activities(204.9)(51.2)
Effect of exchange rate changes on cash, cash equivalents and restricted cash7.913.3
Net (decrease) increase in cash, cash equivalents and restricted cash(165.5)1.0

ITEM 1. UNAUDITED CONDENSED CONSOLIDATED FINANCIAL STATEMENTS

FAQ

What is Bruker's share buybacks?
Bruker (BRKR) reported share buybacks of $0 in Q1 2026.
How has Bruker's share buybacks changed year-over-year?
Bruker's share buybacks decreased by 100.0% year-over-year, from $10M to $0.
What is the long-term trend for Bruker's share buybacks?
Over 3 years (2021 to 2024), Bruker's share buybacks has grown at a -100.0% compound annual growth rate (CAGR), from $153.3M to $0.
What does share buybacks mean?
Cash used to buy back the company's own shares on the open market or through structured programs, reducing shares outstanding.

Ask your AI about Bruker's share buybacks.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude